Diosmin as Adjuvant Therapy in Treatment of Non-bleeding Peptic Ulcer
Non-bleeding Peptic Ulcer
About this trial
This is an interventional treatment trial for Non-bleeding Peptic Ulcer
Eligibility Criteria
Inclusion Criteria: -. Age 25-65 years old. Patients of both gender (male and female). Non-bleeding Peptic ulcer Patients (duodenal &gastric) diagnosed by endoscopy. Exclusion Criteria: The presence of other factors that can lead to gastric bleeding other than peptic ulcer. Patients with cancerous disease Breast-feeding. Surgically altered stomach ( bariatric surgery), Patient with liver disease. Bleeding & perforated peptic ulcer.
Sites / Locations
- Tanta UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
No Intervention
Active Comparator
Control group
Diosmin group
this group will include 22 patients who will receive anti peptic ulcer only for 2 months.
this group will include 22 patients who will receive anti peptic ulcer and diosmin 500 mg twice daily for 2 months.